News

BioM's articles and press releases about the Bavarian biotechnology sector


m4 Award 2021: 2,5 million euros for five innovative biomedical projects from Bavaria

The win­ners of the Bav­ari­an pre-found­ing com­pet­i­tion m4 Award 2021 have their fin­ger on the pulse with in­nov­at­ive bio­med­ic­al…

Consequences of the coronavirus pandemic for Bavarian companies

BioM con­duc­ted its second Bav­aria-wide com­pany sur­vey on the con­sequences of the coronavir­us pan­dem­ic on com­pan­ies in the…

Fraunhofer IKS invites Bavarian Pharmaceutical and Biotech companies for collaboration in quantum computing

The Fraunhofer In­sti­tute for Cog­nit­ive Sys­tems (Fraunhofer IKS) has re­cently won Bav­ari­an pro­ject tenders on the sub­ject of…

Munich proves its strength against COVID-19 at
22. Pharma Trend - Image and Innovation Award

On Septem­ber 14, the win­ners of the "Most In­nov­at­ive Product" award in the cat­egory of leap in­nov­a­tions were an­nounced at the…

HTID - HealthTech Innovation Days 2021

The HealthTech In­nov­a­tion Days (HTID), co-or­gan­ized by EIT Health and HealthTech For Care (foun­ded by France Bi­otech), will take…

European Biotech & Pharma Virtual Partnering Conference 2021

The European Bi­otech & Pharma Vir­tu­al Part­ner­ing Con­fer­ence 2021. The four day event will take place from 27 to 30 Septem­ber 2021…

BioM and SmiLe launch BioTech Bootcamp program with Merck -

new deadline: August 8th

You want to de­vel­op and com­mer­cial­ize your busi­ness ideas in bi­o­tech­no­logy? In col­lab­or­a­tion with SmiLe, one of Europe's…

EU matchmaking event on COVID-19 therapeutics

Fol­low­ing the ad­op­tion of the EU Strategy for COVID-19 Thera­peut­ics, the European Com­mis­sion’s Task Force for In­dus­tri­al Scale-Up…

Your Market Entry Plan for Japan

Are you con­sid­er­ing mar­ket­ing a product or ser­vice in Japan? Do you need a pro­fes­sion­al mar­ket entry plan? “Keys to Japan” is a…

Innovative Molecules: 20 million Euro against Herpes

Mu­nich-based In­nov­at­ive Molecules has closed a EUR 20 mil­lion Ser­ies A fin­an­cing round led by LSP (Life Sciences Part­ners).…